SAN FRANCISCO, CA—Esprit BTK (Abbott Vascular), an everolimus-eluting resorbable scaffold, is safe and effective in the treatment of infrapopliteal chronic limb-threatening ischemia (CLTI) compared ...
Please provide your email address to receive an email when new articles are posted on . In patients with CLTI, there was no difference in wound healing parameters between a drug-eluting scaffold and ...
The trial's primary efficacy endpoint -- freedom from amputation above the ankle of the target limb, occlusion of the target vessel, clinically driven revascularization of the target lesion, and ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results